Vestal Point Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.33M	Buy	+95,000	New	+$1.33M	0.07%	68
2024 Q1	–	Sell	-2,700,000	Closed	-$8.72M	–	59
2023 Q4	$8.72M	Buy	+2,700,000	New	+$8.72M	0.92%	28